Tiziana Life Sciences Ltd vs Theriva Biologics, Inc. — Valuation Comparison 2026
Access all valuation models for TLSA vs TOVX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →TOVX scores higher with a 4.0/10 quality rating vs TLSA's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing Tiziana Life Sciences Ltd (TLSA) and Theriva Biologics, Inc. (TOVX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
TLSA currently trades at $1.41 with a QOC of 1.7/10, while TOVX trades at $0.28 with a QOC of 4.0/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).